In CRC cell lines, the suppression of CD133 reduces the expression of HER3 (human epidermal growth factor receptor 3) and inhibits the activation of EGFR and HER2 (human epidermal growth factor receptor 2) without disrupting their translation [72]. This evidence concerns the gene ERBB3 and colorectal carcinoma.